Skip to content

Evaluation of an Innovative Medical Device Supporting Orthopedic Surgical Interventions

Virtual Implant Planning System - A Method to Support Image-guided Surgical Interventions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01670344
Acronym
VIPS
Enrollment
80
Registered
2012-08-22
Start date
2012-07-31
Completion date
2013-06-30
Last updated
2013-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Distal End of Radius

Brief summary

This study is a randomized, controlled, 2-arm, open trial to evaluate an innovative positioning system in the clinical setting of orthopedic surgery. Aim of the study is the validation and comparison of the innovative medical device with the current standard method.

Interventions

PROCEDURETreatment with investigational method (virtual implant positioning system)
PROCEDURETreatment with surgical standard of care

Sponsors

Siemens Healthcare QT
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with diastal fracture of the radius * Patients with the mentioned fracture and indication for surgical treatment according to national guidelines * Age \>/= 18 years of age * Patients willing to participate and after having given their informed consent in written form

Exclusion criteria

* Participation in other interventional clinical trials * Pregnant or lactating women

Design outcomes

Primary

MeasureTime frameDescription
Number of screw replacements in both treatments armsParticipants will be followed for the duration of the hospital stay, an expected average of 3 daysThe number of screw replacements in both treatment arms will be assessed to evaluate the investigational method in comparison to the standard of care (arm B)

Secondary

MeasureTime frame
Comparison of the investigational method to the standard of care regarding radiation time.Participants will be followed for the duration of the hospital stay, an expected average of 3 days
Number of adverse events and serious adverse events during the clinical investigarion.Participants will be followed for the duration of the hospital stay, an expected average of 3 days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026